Login / Signup

Acute Liver Rejection in a Multiple Myeloma Patient Treated with Lenalidomide.

Iuliana VaxmanJohn EatonHee Eun LeeMorie A Gertz
Published in: Case reports in transplantation (2020)
Herein we present a patient that underwent a liver transplant due to primary biliary cholangitis (PBC) and after 9 years developed multiple myeloma. Following the cessation of mycophenolate mofetil and 2 weeks after lenalidomide treatment was started, the patient experienced acute cellular rejection. The patient recovered after treatment with corticosteroids, resumption of mycophenolate mofetil, and cessation of lenalidomide. Lenalidomide-associated allograft rejection has been reported in other organs. However, this is the first case report of liver rejection induced by lenalidomide.
Keyphrases
  • multiple myeloma
  • case report
  • newly diagnosed
  • stem cell transplantation
  • liver failure
  • intensive care unit
  • drug induced